Skip to main content

Table 3 Spearman correlation and multiple regression analysis between pH values and the main clinical and metabolic features in all population and in the two groups with type 1 diabetes before (Group I) and during (Group II) COVID-19 pandemic

From: Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic

 

Spearman Correlation

Multiple regression analysis

 

Whole population

Group I

Group II

Group I

Group II

 

Beta

P

Beta

P

Beta

P

Beta

P

Beta

P

Age (years)

0.09

0.20

0.02

0.79

0.26

0.10

    

Weight-SDS

0.28

 < 0.001

0.24

0.005

0.24

0.13

0.32

0.04

-0.08

0.70

Height-SDS

0.12

0.11

0.07

0.39

0.12

0.44

    

BMI-SDS

0.19

0.01

0.14

0.09

0.21

0.19

-0.29

0.06

0.09

0.61

Glycemia (mg/dL)

-0.28

 < 0.001

-0.23

0.007

-0.47

0.002

-0.14

0.24

-0.14

0.43

HbA1c (mmol/mol)

-0.33

 < 0.001

-0.40

 < 0.001

-0.37

0.01

-0.15

0.25

-0.14

0.37

C-peptide (ng/mL)

0.35

 < 0.001

0.33

0.001

0.31

0.04

0.25

0.05

0.41

0.008

GAD Ab (U/ml)

-0.01

0.90

-0.04

0.61

0.06

0.73

    

IA2 Ab (U/ml)

-0.12

0.15

-0.15

0.11

-0.15

0.35

    

TSH (µUI/ml)

-0.07

0.37

-0.10

0.29

-0.14

0.36

    

FT4 (ng/dL)

0.04

0.63

-0.09

0.34

-0.10

0.53

    

Total Cholesterol (mg/dL)

0.01

0.88

0.04

0.63

0.014

0.93

    

HDL Cholesterol (mg/dL)

0.11

0.23

-0.002

0.96

0.36

0.03

0.054

0.67

0.54

0.01

LDL Cholesterol (mg/dL)

0.08

0.46

0.16

0.31

0.19

0.27

    

Tryglicerides (mg/dL)

-0.15

0.07

-0.03

0.72

-0.43

0.009

-0.05

0.65

-1.84

0.01

TG/HDL ratio

-0.23

0.01

-0.16

0.89

-0.51

0.002

-0.06

0.6

1.78

0.03

  1. Legend Significant values P ≤ 0.05. BMI-SDS Standard Deviation Scores-Body Mass Index; HbA1c Hemoglobin A1c. IA2 Tyrosine Phosphatase antibodies IA-2. TSH  Thyroid-Stimulating Hormone. fT4 free-Thyroxine.